A Long-term Efficacy, Safety, and Tolerability Study of BOTOX® in Patients With Chronic Migraine
Study Identifier
GMA-BTX-CM-10-001
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Study Details
Medical Condition
Study Drug
Phase
Phase 4
Sex
Female & Male
Age
18+ years
Protocol Summary
This open-label study will assess the long-term efficacy, safety, and tolerability of onabotulinumtoxinA administered for prophylaxis of headaches in patients with chronic migraine.
Study Locations
Location
Status
Location
Arizona Neurological Institute
Scottsdale, Arizona, United States, 85255-7450
Status
Not applicable
Location
The Research Center of Southern California, LLC
Encinitas, California, United States, 92024
Status
Not applicable
Location
USC Neurology
Los Angeles, California, United States, 90033
Status
Not applicable
Location
UCSF Headache Center
San Francisco, California, United States, 94133
Status
Not applicable
Location
Neurological Research Institute
Santa Monica, California, United States, 90404
Status
Not applicable
Location
Advanced Neurosciences Research, LLC
Fort Collins, Colorado, United States, 80528
Status
Not applicable
Showing {first} - {last} of {total} Results